To the editor

New England Journal of Medicine

Volumn 360, Issue 13, 2009, Pages 1362-1363

  Roukos, Dimitrios H ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; GENE MUTATION; GENETIC ANALYSIS; HUMAN; LETTER; MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; ADJUVANT THERAPY; BREAST; BREAST TUMOR; NOTE; PIGMENT DISORDER; RADIATION EXPOSURE; SEGMENTAL MASTECTOMY; SKIN; GENETIC DISORDER; GENETICS; MUTATION; TUMOR RECURRENCE; TUMOR SUPPRESSOR GENE;

BREAST; BREAST NEOPLASMS; HUMANS; MASTECTOMY, SEGMENTAL; PIGMENTATION DISORDERS; RADIOTHERAPY, ADJUVANT; SKIN; GENES, BRCA1; GENES, BRCA2; GENETIC DISEASES, INBORN; GERM-LINE MUTATION; MASTECTOMY; NEOPLASM RECURRENCE, LOCAL;

EID: 63849104390     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc090162     Document Type: Article

References (5)

1. Roukos DH, Briasoulis E. Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome. Nat Clin Pract Oncol 2007;4:578-90.
2. Metcalfe K, Lynch HT, Ghadirian P, et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 2004;22:2328-35.
3. Pierce LJ, Levin AM, Rebbeck TR, et al. Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. J Clin Oncol 2006;24:2437-43.
4. Hooning MJ, Aleman BM, Hauptmann M, et al. Roles of radiotherapy and chemotherapy in the development of contralat- eral breast cancer. J Clin Oncol 2008;26:5561-8.
5. Roukos DH. Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery. Expert Rev Mol Diagn 2008;8:587-97.